手机使用与痴呆发病率之间的关联:使用英国生物银行进行的一项前性队列研究
Houyu Zhao1,2, Qiaorui Wen3,4, Lin Zhuo5
1Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China, houyu-zhao@pku.edu.cn.
Gerontology
|July 26, 2023
概括
每天使用手机与痴呆症风险降低有关. 这种关联可能源于社会和心理参与的增加,这表明对认知健康的潜在益处.
科学领域:
- 老年学是一门学科.
- 流行病学 流行病学
- 神经科学是一个神经科学.
背景情况:
- 越来越多的人采用手机,人们对潜在的痴呆风险感到担忧.
- 这项研究探讨了日常使用手机与痴呆症发病率之间的关联.
研究的目的:
- 调查社区居民成年人手机使用与痴呆风险之间的关系.
- 分析来自英国生物库的数据,以深入了解认知健康和技术使用.
主要方法:
- 包括60岁以上的英国生物银行参与者在基线没有痴呆症的前性队列研究.
- 考克斯回归模型调整了许多共同变量,以评估手机使用和痴呆风险.
- 基于使用电话的时间,分析痴呆发病率的危险比率 (HR) 和置信区间 (CI).
主要成果:
- 分析了213,181名参与者,平均随访时间为12.4年;发现了6,344例痴呆病例.
- 移动电话使用在各种使用水平 (例如,HR 0.78 30-59分钟/周) 上显示出与减少痴呆风险的适度关联.
- 该协会部分通过家庭/朋友访问 (2.62%) 和休/社交活动 (2.22%) 进行调解.
结论:
- 每日使用手机与英国老年人痴呆症风险降低有显著关联.
- 改善的社会和心理活动似乎调解了这种保护性关联.
- 研究结果表明,与手机媒介的社交参与相关的潜在认知益处.
相关概念视频
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Bias in Epidemiological Studies
356
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
356
Alzheimer's Disease: Overview
524
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
524


